LowSALT CKD: lower pressure and urinary protein, not a kidney-failure verdict
A small crossover trial measured blood pressure, fluid volume and urinary markers rather than long-term kidney outcomes.

Illustrative food image, not a photograph of the study intervention.
Twenty participants, a specific kidney setting
The LowSALT CKD study tested a focused question in 20 adults with hypertension and stage 3–4 chronic kidney disease. Its first phase compared high and low sodium intake in a double-blind, placebo-controlled randomized crossover design. This was not a population survey comparing people who happened to eat differently. Participants experienced the study conditions within a crossover experiment, giving the comparison a different evidential footing from an association. The population still matters: these were adults with both hypertension and moderate-to-severe CKD. The abstract does not establish the same magnitude of response in every kidney condition or in people without CKD.
McMahon EJ, Bauer JD, Hawley CM, Isbel NM et al.. J Am Soc Nephrol, 2013. PMID 24204003 · DOI
The pressure result has units
Sodium restriction reduced systolic and diastolic blood pressure by an average of 10 and 4 mm Hg, respectively. The reported 95% confidence intervals were 5 to 15 mm Hg for systolic pressure and 1 to 6 mm Hg for diastolic pressure. Those are measured pressure differences, not percentages of kidney protection. Ambulatory blood pressure was among the trial's assessed outcomes, alongside measures of fluid status and urinary protein. Keeping the units visible prevents a persuasive result from becoming a different claim. A reduction of 10 mm Hg is not evidence that kidney-failure events fell by any particular percentage.
McMahon EJ, Bauer JD, Hawley CM, Isbel NM et al.. J Am Soc Nephrol, 2013. PMID 24204003 · DOI
Several markers moved together
The abstract also reports significant reductions in extracellular fluid volume, albuminuria and proteinuria during sodium restriction. Fluid status was assessed with a body composition monitor, while the investigators measured 24-hour protein and albumin excretion. These findings make the study broader than a blood-pressure-only comparison, but they remain measurements rather than a count of later kidney-failure events. The investigators also assessed renin, aldosterone and arterial stiffness; the abstract does not supply an effect estimate for every assessed variable. It would therefore be inaccurate to describe every measurement in the protocol as an established benefit of the lower-sodium condition.
McMahon EJ, Bauer JD, Hawley CM, Isbel NM et al.. J Am Soc Nephrol, 2013. PMID 24204003 · DOI
A strong signal in a small experiment
The authors describe the blood-pressure change as clinically important and suggest that patients with CKD may be particularly salt sensitive. They also explicitly call for larger samples and longer interventions to confirm the benefits. That qualification belongs beside the favorable results, not hidden after them. Twenty participants can provide a useful experimental signal without settling questions about long-term progression or cardiovascular events. This article therefore reports what sodium restriction changed in the trial, rather than converting the findings into an individual sodium target. No recipe pairing accompanies this kidney article, and the trial is not presented as a universal renal menu.
McMahon EJ, Bauer JD, Hawley CM, Isbel NM et al.. J Am Soc Nephrol, 2013. PMID 24204003 · DOI